SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (58)1/5/1999 7:59:00 AM
From: Scott H. Davis  Respond to of 613
 
I think at least 2 of us has AXPH. Got a news item. "Axys Pharmaceuticals Initiates Phase I Clinical Trial of Lead Topical
Tryptase Inhibitor APC 2059, for Treatment of Psoriasis" FYI Scott



To: Brander who wrote (58)1/5/1999 8:32:00 AM
From: Arthur Radley  Respond to of 613
 
Brad,
In my recent move, I missed place your office address. Send it to me by PM and tell me which "medicine" you prefer.(:>>>>)
Now for my excuse.....44 day layoff since FSU played a game and I guess I might add.....22 guys on the UT team were better when they were on the field.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News